News Image

Ocugen Provides Business Update with First Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: May 9, 2025

Conference Call and Webcast Today at 8:30 a.m. ET

MALVERN, Pa., May 09, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported first quarter 2025 financial results along with a general business update.

Read more at globenewswire.com

OCUGEN INC

NASDAQ:OCGN (7/23/2025, 6:27:59 PM)

After market: 1.1692 0 (-0.07%)

1.17

+0.14 (+13.59%)



Find more stocks in the Stock Screener

Follow ChartMill for more